Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
This randomized phase III trial studies whether weight loss in overweight and obese women
may prevent breast cancer from coming back (recurrence). Previous studies have found that
women who are overweight or obese when their breast cancer is found (diagnosed) have a
greater risk of their breast cancer recurring, as compared to women who were thinner when
their cancer was diagnosed. This study aims to test whether overweight or obese women who
take part in a weight loss program after being diagnosed with breast cancer have a lower
rate of cancer recurrence as compared to women who do not take part in the weight loss
program. This study will help to show whether weight loss programs should be a part of
breast cancer treatment.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society